U.S. President Donald Trump signed an executive order on Saturday intended to speed up access to medical research and treatment based on psychedelic drugs.

The order instructs the U.S. Food and Drug Administration to expedite the review of drugs such as ibogaine, which U.S. military veteran groups ​have said can help treat post-traumatic stress disorder.

Health Secretary Robert F. Kennedy Jr. has championed the idea of using drugs ‌such as ‌ibogaine as an alternative treatment for mental health conditions such as depression.

Adblock test (Why?)